4.7 Article

X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options

Related references

Note: Only part of the references are listed.
Article Hematology

Wiskott-Aldrich Syndrome: Diagnosis, Clinical and Laboratory Manifestations, and Treatment

Hans D. Ochs et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)

Article Biotechnology & Applied Microbiology

Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott-Aldrich Syndrome in Preclinical Models

Francesco Marangoni et al.

MOLECULAR THERAPY (2009)

Article Hematology

Wiskott-Aldrich syndrome

Luigi D. Notarangelo et al.

CURRENT OPINION IN HEMATOLOGY (2008)

Article Medicine, General & Internal

The genotype of the original Wiskott phenotype

Vera Binder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Review Allergy

The Wiskott-Aldrich syndrome

HD Ochs et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)

Review Rheumatology

Autoimmunity in Wiskott-Aldrich syndrome

SH Schurman et al.

CURRENT OPINION IN RHEUMATOLOGY (2003)

Article Medicine, Research & Experimental

Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings

T Wada et al.

JOURNAL OF CLINICAL INVESTIGATION (2003)